Shield agrees to buy Echodyne for $5.3bn and raises $2.5bn to fund it
What happened
On 5 November, the defence-technology group Shield announced it will acquire Echodyne, a maker of radars used to detect drones. The $5.3bn price is $4.8bn at closing plus up to $500m that depends on performance targets. To pay for it, Shield is raising $2.5bn: a $1bn funding round at a $28.8bn valuation, $1bn of structured equity from funds managed by Blackstone, and $500m of debt led by JPMorgan. Closing is expected in early 2027.
Why it matters
The buyer is a private company, so it paid for the deal by raising capital rather than by issuing listed shares. The earn-out lets the seller get the full price only if the business delivers, which shifts part of the risk back to Echodyne. Mixing equity, structured equity and debt is a live example of how a financing package is built around an acquisition.
Say it in 30 seconds
A deal I'd pick is Shield's purchase of Echodyne, announced on 5 November: $5.3 billion, of which up to $500 million is an earn-out tied to performance. What interests me is the financing: Shield raised $2.5 billion at the same time, split between equity, Blackstone's structured equity and a $500 million loan. It shows that a private company can fund a large acquisition without a listed currency, and that the earn-out keeps the seller exposed to the result.
You may be asked
- Why would a buyer use an earn-out?
- How does paying with new equity differ from paying with debt?